Evidence map›Paper›PMID 23609450›Full record

ArticleThe Journal of biological chemistry2013

Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species.

Yingke Li, Peng Zhang, Chengcai Wang, Chaofeng Han, Jun Meng, Xingguang Liu, Sheng Xu, Nan Li, Qingqing Wang, Xueyin Shi and 1 more

Abstract readCase Reports
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Reprogramming immunity with itaconate: metabolic mechanisms and therapeutic perspectives.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. High glucose induces pro-inflammatory polarization of macrophages by inhibiting immune-responsive gene 1 expression.Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. The role and therapeutic potential of itaconate in lung disease.Cellular & molecular biology letters · 2024
    Review
  19. Article
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yingke LiNational Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, Shanghai 200433; Department of Anesthesiology, Changzheng Hospital, Second Military Medical University, Shanghai 200003.
Peng ZhangNational Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, Shanghai 200433.
Chengcai WangDepartment of Anesthesiology, Changzheng Hospital, Second Military Medical University, Shanghai 200003.
Chaofeng HanNational Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, Shanghai 200433.
Jun MengInstitute of Immunology, Zhejiang University School of Medicine, Hangzhou 310058.
Xingguang LiuNational Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, Shanghai 200433.
Sheng XuNational Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, Shanghai 200433.
Nan LiNational Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, Shanghai 200433.
Qingqing WangInstitute of Immunology, Zhejiang University School of Medicine, Hangzhou 310058.
Xueyin ShiDepartment of Anesthesiology, Changzheng Hospital, Second Military Medical University, Shanghai 200003. Electronic address: shixueyin1128@yahoo.com.cn.
Xuetao CaoNational Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, Shanghai 200433; Institute of Immunology, Zhejiang University School of Medicine, Hangzhou 310058; National Key Laboratory of Medical Molecular Biology and Department of Immunology, Chinese Academy of Medical Sciences, Beijing 100021, China. Electronic address: caoxt@immunol.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis-associated immunosuppression (SAIS) is regarded as one of main causes for the death of septic patients at the late stage because of the decreased innate immunity with a more opportunistic infection. LPS-tolerized macrophages, which are re-challenged by LPS after prior exposure to LPS, are regarded as the common model of hypo-responsiveness for SAIS. However, the molecular mechanisms of endotoxin tolerance and SAIS remain to be fully elucidated. In addition, negative regulation of the Toll-like receptor (TLR)-triggered innate inflammatory response needs further investigation. Here we show that expression of immune responsive gene 1 (IRG1) was highly up-regulated in the peripheral blood mononuclear cells of septic patients and in LPS-tolerized mouse macrophages. IRG1 significantly suppressed TLR-triggered production of proinflammatory cytokines TNF-α, IL-6, and IFN-β in LPS-tolerized macrophages, with the elevated expression of reactive oxygen species (ROS) and A20. Moreover, ROS enhanced A20 expression by increasing the H3K4me3 modification of histone on the A20 promoter domain, and supplement of the ROS abrogated the IRG1 knockdown function in breaking endotoxin tolerance by increasing A20 expression. Our results demonstrate that inducible IRG1 promotes endotoxin tolerance by increasing A20 expression through ROS, indicating a new molecular mechanism regulating hypoinflammation of sepsis and endotoxin tolerance.

Indexed as

AnimalsCarboxy-LyasesCysteine EndopeptidasesDNA-Binding ProteinsFemaleGene Expression RegulationGene Knockdown TechniquesHistonesHumansHydro-LyasesImmune ToleranceImmunity, InnateInterferon-betaInterleukin-6Intracellular Signaling Peptides and ProteinsLipopolysaccharidesACOD1 protein, humanAcod1 protein, mouseCarboxy-LyasesCysteine EndopeptidasesDNA-Binding ProteinsHistonesHydro-LyasesIL6 protein, humanInterferon-betaInterleukin-6Intracellular Signaling Peptides and ProteinsLipopolysaccharidesNuclear ProteinsProteinsReactive Oxygen SpeciesTNFAIP3 protein, humanTnfaip3 protein, mouseTumor Necrosis Factor-alphaTumor Necrosis Factor alpha-Induced Protein 3Ubiquitin-Protein LigasesA20Endotoxin ToleranceImmune Responsive Gene 1InflammationInnate ImmunityMacrophagesReactive Oxygen Species (ROS)ROSToll-like Receptors (TLR)

Identifiers

PMID23609450
PMCPMC3675562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.